Melanotan II and 'tan maintenance': what the peptide scene gets wrong
Quick answer
Melanotan II is a synthetic melanocortin receptor agonist that produces measurable skin pigmentation by stimulating melanin synthesis, a mechanism supported by peer-reviewed human studies. It is not FDA-approved, has a documented side effect profile including nausea and cardiovascular flushing, and carries unresolved concerns about atypical nevus changes with long-term unmonitored use. The creator's reported results are biologically plausible, but the product he used came from an unregulated source with no verified purity or sterility standards.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @harrian_ actually say?
@harrian_ ran a self-described seven-day experiment using daily doses of Melanotan II (which he calls "Malano 10") and returned from vacation reporting visible tanning results. He says he noticed "a lot more golden or bronze" skin tone and credits the peptide as a success. He also mentions "a little bit more facial clarity" but appropriately caveats that he was on vacation and can't fully attribute that to the peptide. He plans to drop to once-weekly dosing to maintain his tan. The jellyfish encounter he jokes about is, notably, not a controlled variable in any meaningful sense.
To his credit, he keeps the claims relatively modest. He doesn't claim Melanotan II cured anything, reversed aging, or built muscle. He's describing cosmetic tanning, which is actually the most documented use of this compound in the research literature.
Does the science back this up?
On the core tanning claim, yes, the mechanism is real and studied. Melanotan II is a synthetic analogue of alpha-melanocyte-stimulating hormone (alpha-MSH). It binds melanocortin receptors, particularly MC1R, triggering increased melanin synthesis. That is not in dispute.
Barnetson et al. (2006, Journal of Investigative Dermatology) showed that afamelanotide, a related MC1R agonist, produced measurable pigmentation in human subjects. King et al. (2009, British Journal of Dermatology) confirmed that Melanotan II specifically does increase skin pigmentation in clinical settings. So the biological pathway @harrian_ is exploiting is legitimate.
The part that gets complicated is the safety profile. Melanotan II is not approved by the FDA or any major regulatory body for cosmetic tanning. It has documented side effects including nausea, facial flushing, spontaneous erections, and more seriously, case reports of atypical mole changes that have raised dermatologist concerns about melanoma risk when used without supervision (Langan et al., 2020, BMJ Case Reports).
What did they get wrong (or right)?
He got the tanning mechanism right. The peptide works the way he's implying it works, and his results are consistent with what the literature predicts. The caveat on facial clarity was genuinely good epistemic hygiene. Not many TikTok creators admit they can't attribute a result to their experiment. That deserves credit.
What he didn't address, and what viewers likely won't ask, is the regulatory and safety context. Melanotan II is not a tested, approved product. The sources selling it for injection are unregulated, purity is variable, and dosing is entirely self-directed. The shift from daily to weekly maintenance dosing sounds systematic, but there is no published clinical protocol for recreational cosmetic Melanotan II use because none exists.
He also didn't mention that Melanotan II binds MC3R and MC4R in addition to MC1R, which is why the side effect profile goes well beyond skin. That's not a minor footnote. Spontaneous erections and nausea were common enough in early trials that they affected study completion rates (Wessells et al., 2000, Journal of Urology).
What should you actually know?
Melanotan II works as a tanning agent by a real, studied mechanism. That part is not pseudoscience. But "it works" and "it's safe to use without supervision" are two different statements, and this video only really addresses the first.
The bigger issue is the supply chain. Melanotan II sold for recreational use comes from unregulated sources. You don't know the purity, concentration, or sterility of what you're injecting. Compounded peptides from regulated telehealth pharmacies are subject to USP standards. Random online sources are not, and the product is frequently mislabeled or contaminated (Lippi et al., 2018, Clinical Chemistry and Laboratory Medicine).
If you're interested in peptide-based approaches to skin health or recovery, a licensed provider can walk through what's actually available through legal, regulated channels. Self-experimenting with unregulated injectable peptides based on a TikTok results video is a different category of decision entirely.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 11 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Melanotan II and 'tan maintenance': what the peptide scene gets wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
SCENESSE (afamelanotide implant) FDA Prescribing Information
Afamelanotide (an alpha-MSH analog) is the only FDA-approved melanocortin peptide of this class, and only to increase pain-free light exposure in erythropoietic protoporphyria, not for cosmetic tanning.
FDA
Afamelanotide for Erythropoietic Protoporphyria
Randomized placebo-controlled trials (NEJM) behind the afamelanotide approval; this is the legitimate human melanocortin evidence, distinct from unapproved tanning peptides.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Melanotan II and 'tan maintenance': what the peptide scene gets wrong should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
Melanotan II is a synthetic melanocortin receptor agonist that produces measurable skin pigmentation by stimulating melanin synthesis, a mechanism supported by peer-reviewed human studies.
FormBlends verdict
Melanotan II is a synthetic melanocortin receptor agonist that produces measurable skin pigmentation by stimulating melanin synthesis, a mechanism supported by peer-reviewed human studies. It is not FDA-approved, has a documented side effect profile including nausea and cardiovascular flushing, and carries unresolved concerns about atypical nevus changes with long-term unmonitored use. The creator's reported results are biologically plausible, but the product he used came from an unregulated source with no verified purity or sterility standards.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Melanotan II is a synthetic melanocortin receptor agonist that produces measurable skin pigmentation by stimulating melanin synthesis, a mechanism supported by peer-reviewed human studies. It is not FDA-approved, has a documented side effect profile including nausea and cardiovascular flushing, and carries unresolved concerns about atypical nevus changes with long-term unmonitored use. The creator's reported results are biologically plausible, but the product he used came from an unregulated source with no verified purity or sterility standards.
- Melanotan II binds MC1R receptors to increase melanin synthesis, a mechanism confirmed in peer-reviewed human trials including King et al. (2009, British Journal of Dermatology).
- The peptide is not FDA-approved for any use, including cosmetic tanning, meaning no regulated dosing protocol or safety standard applies to over-the-counter sources.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Melanotan II binds MC1R receptors to increase melanin synthesis, a mechanism confirmed in peer-reviewed human trials including King et al. (2009, British Journal of Dermatology).
- The peptide is not FDA-approved for any use, including cosmetic tanning, meaning no regulated dosing protocol or safety standard applies to over-the-counter sources.
- Early clinical trials reported nausea and spontaneous erections as common enough side effects to affect participant completion rates (Wessells et al., 2000, Journal of Urology).
- Unregulated injectable peptides sold online have no verified purity, concentration, or sterility standards, creating contamination and mislabeling risks beyond the peptide's own side effect profile.
- Case reports have flagged atypical nevus changes in users of unsupervised Melanotan II, raising dermatologist concerns about melanoma risk with long-term unmonitored use (Langan et al., 2020, BMJ Case Reports).
- The creator's result is biologically plausible but uncontrolled. He was on vacation with UV exposure, making it impossible to isolate the peptide's tanning contribution from sun exposure alone.
- Peptide therapy through a regulated telehealth provider involves compounded products meeting USP standards, physician oversight, and documented safety monitoring. That is a different category from self-sourced injectables.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
harrian · TikTok creator
12.2K views on this video
Gonna keep using it to maintain my tan but dropping frequency #gym #gymtok #creatorsearchinsights
Sources & references
- [1]Barnetson et al. (2006)
- [2]King et al. (2009)
- [3]Langan et al., 2020
- [4]Wessells et al., 2000
- [5]Lippi et al., 2018
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by harrian, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.